M&A

Is a Target and CVS Merger Now Inevitable?
Motley Fool
Sun, 04/14/19 - 03:59 pm
CVS
Target
M&A
Pharma AbbVie, Shire investors agree to settle lawsuit over scuttled tax-inversion deal
Fierce Pharma
Sat, 04/13/19 - 12:18 pm
AbbVie
Shire
taxes
tax inversions
M&A
Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene
CNBC
Sat, 04/13/19 - 12:03 pm
M&A
Bristol-Myers Squibb
Celgene
Pharma CEOs
Giovanni Caforio
The Bristol-Celgene merger is approved. Here are 8 challenges ahead
Stat
Fri, 04/12/19 - 11:54 pm
Bristol-Myers Squibb
Celgene
M&A
Here's Why Biohaven Pharmaceutical Jumped 20% Today
Motley Fool
Fri, 04/12/19 - 11:37 pm
Biohaven Pharmaceuticals
M&A
Syncona gene therapy start-ups Gyroscope, Orbit merge
BioCentury
Thu, 04/11/19 - 07:16 pm
Syncona
Gyroscope
Orbit
gene therapy
retinal disease
M&A
It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready
Endpoints
Tue, 04/9/19 - 08:31 am
Novartis
M&A
Alcon
Pharma CEOs
Vas Narasimhan
Battered and out of options, Histogenics turns to eye drug developer Ocugen for reverse merger
Endpoints
Mon, 04/8/19 - 12:01 pm
Histogenics
Ocugen
M&A
After Apotex founder's murder, family weighs sale worth up to $3B: report
Fierce Pharma
Fri, 04/5/19 - 11:34 pm
Apotex
generics
Barry Sherman
M&A
1 Biotech That Biogen Should Buy ... but Probably Won't
Motley Fool
Thu, 04/4/19 - 11:26 pm
Biogen
Ionis Pharmaceuticals
M&A
Bristol-Myers' big Celgene buyout showers $187M-plus on Morgan Stanley
Endpoints
Thu, 04/4/19 - 11:07 pm
Bristol-Myers Squibb
Celgene
Morgan Stanley
M&A
Novartis CEO's $50 Billion of Deals Was Just the First Act
Yahoo/Bloomberg
Thu, 04/4/19 - 12:01 pm
Novartis
M&A
Vas Narasimhan
Pharma CEOs
Is Walgreens CEO Pessina Opening Up To A Big Merger?
Forbes
Thu, 04/4/19 - 10:28 am
Walgreens Boots Alliance
M&A
Roche must ask Spark shareholders once again to sell
Biopharma Dive
Wed, 04/3/19 - 12:23 pm
Roche
Spark Therapeutics
gene therapy
M&A
Boehringer Ingelheim buys MacroDel platform developer ICD Therapeutics
Pharmaceutical Business Review
Mon, 04/1/19 - 12:19 pm
Boehringer Ingelheim
MacroDel biologics
M&A
ICD Therapeutics
Smith & Nephew to acquire patient monitor dev Leaf Healthcare
Mass Device
Mon, 04/1/19 - 12:15 pm
Smith & Nephew
patient monitoring
devices
Leaf Healthcare
M&A
Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre
Xconomy
Mon, 04/1/19 - 10:31 am
Novartis
IFM Tre
M&A
anti-inflammatory
inflammation
After winning key support for Celgene buyout, Bristol-Myers CEO Caforio emerges as clear likely winner in looming shareholder vote
Endpoints
Sun, 03/31/19 - 03:47 pm
Bristol-Myers Squibb
Celgene
M&A
Starboard
Giovanni Caforio
Bristol-Myers scores a critical endorsement for its embattled Celgene merger
Stat
Fri, 03/29/19 - 10:17 am
Bristol-Myers Squibb
Celgene
M&A
Amarin takes application to expand Vascepa label to the FDA as M&A chatter heats up
Endpoints
Fri, 03/29/19 - 10:02 am
Amarin
Vascepa
FDA
M&A

Pages